Development of a core set of domains for data collection in cohorts of patients with ankylosing spondylitis receiving anti-tumor necrosis factor-alpha therapy.

Authors:	Jane Zochling, Joachim Sieper, Désirée van der Heijde, Jürgen Braun,
Language:	Eng.
Date:	05-06-2008
Journal:	The Journal of rheumatology (0315-162X)
Release:	J Rheumatol. 2008 Jun;35(6):1079-82
Abstract:	OBJECTIVE: To create a core set of measurement concepts for use in the creation and maintenance of anti-tumor necrosis factor-alpha patient registries in ankylosing spondylitis (AS). METHODS: A Delphi-based approach was used to identify elements that best identify a patient's clinical state, disease progression, and potential drug-related toxicities. Decision-making was based on systematic literature reviews and clinical experience and expertise. RESULTS: A core set of measurement domains was defined including disease activity and physical function outcomes. Comparison with domains used in existing AS registries showed excellent agreement with current practice. CONCLUSION: This core set is a basis for data collection across AS populations.
Copyright:	The Journal of rheumatology Menzies Research Institute, Hobart, Australia.
Full text:	EBSCO - HTML (needs subscription) Journal of Rheumatology - HTML (needs subscription)